Core Viewpoint - The report from China Merchants Securities indicates that Easy Health (02661) has successfully transformed from a "crowdfunding platform" to a closed-loop ecosystem of "AI + health services + insurance protection," significantly increasing the proportion of health service revenue [1] Group 1: Business Transformation - The company has enhanced its operational efficiency and scale effects through deep AI integration in content production, precise conversion, and risk control systems, leading to optimized revenue structure and released profitability [1] - The firm is rated "Buy" with a target price of HKD 109.4, reflecting confidence in its long-term commercial resilience and counter-cyclical capabilities supported by a multi-payer structure [1] Group 2: Competitive Positioning - In a highly fragmented digital healthcare market, the company has achieved differentiated competition by focusing on public health education, contrasting with serious medical platforms like Yimaitong [1] - Leveraging the strong brand trust built from its origins in crowdfunding, the company has positioned itself as the starting point in the patient decision-making chain, particularly appealing to younger patients who prefer video consultations [1] Group 3: Market Opportunities - The company's consumer-oriented health content, addressing issues like hair loss, sleep, and chronic disease management, has a broader audience and creates a strong psychological presence at both the scene and patient ends [1] - The firm is expected to have further value release potential at current stock price levels, with stock performance primarily dependent on the management's ability to deliver on transformation results [1]